Clinical Trials Sponsored by Provectus Biopharmaceuticals, Inc.
Total 124 results
-
Provectus Biopharmaceuticals, Inc.Active, not recruitingMetastatic Colorectal Cancer | Hepatocellular Carcinoma | Metastatic Lung Cancer | Metastatic Breast Cancer | Metastatic Melanoma | Metastatic Uveal Melanoma | Metastatic Pancreatic Cancer | Metastatic Colon Cancer | Metastatic Ocular Melanoma | Cancer Metastatic to the LiverUnited States
-
Provectus Biopharmaceuticals, Inc.Active, not recruiting
-
Provectus Biopharmaceuticals, Inc.Active, not recruitingNeuroendocrine Tumors Metastatic to the LiverAustralia
-
Provectus Biopharmaceuticals, Inc.TerminatedCutaneous MelanomaUnited States, Mexico, France, Germany, Italy
-
Provectus Biopharmaceuticals, Inc.No longer availableCutaneous or Subcutaneous Tumors Where There is no Comparable or Satisfactory | Approved Alternative TherapyUnited States, Australia
-
Gracell Biopharmaceuticals, Inc.RecruitingRelapsed/ Refractory Multiple MyelomaUnited States
-
NGM Biopharmaceuticals, IncCompletedGeographic AtrophyUnited States
-
RegeneRx Biopharmaceuticals, Inc.WithdrawnST Elevation Myocardial Infarction | Acute Myocardial Infarction | STEMI
-
NGM Biopharmaceuticals, IncCompleted
-
Alder Biopharmaceuticals, Inc.CompletedMigraine DisordersUnited States, Georgia
-
NGM Biopharmaceuticals, IncCompletedImpaired Renal FunctionUnited States
-
Alder Biopharmaceuticals, Inc.Completed
-
NGM Biopharmaceuticals, IncCompleted
-
RegeneRx Biopharmaceuticals, Inc.Completed
-
NGM Biopharmaceuticals, IncCompletedImpaired Hepatic FunctionUnited States
-
NGM Biopharmaceuticals, IncCompleted
-
Alder Biopharmaceuticals, Inc.CompletedMigraine DisorderUnited States
-
NGM Biopharmaceuticals, IncCompleted
-
NGM Biopharmaceuticals, IncCompleted
-
RegeneRx Biopharmaceuticals, Inc.WithdrawnMyocardial Infarction | Myocardial IschemiaUnited States
-
AgoneX Biopharmaceuticals, Inc.Not yet recruiting
-
NGM Biopharmaceuticals, IncCompletedNonalcoholic Steatohepatitis | Compensated CirrhosisUnited States, Australia, Belgium, France, Germany, Hong Kong, Poland, Puerto Rico, United Kingdom
-
NGM Biopharmaceuticals, IncActive, not recruitingMelanoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Non-small Cell Lung Cancer | Metastatic Castration-resistant Prostate Cancer | Head Neck Squamous Cell CarcinomaUnited States
-
NGM Biopharmaceuticals, IncTerminated
-
NGM Biopharmaceuticals, IncCompletedHealthy MaleUnited States
-
NGM Biopharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Alder Biopharmaceuticals, Inc.CompletedMigraine DisordersUnited States, Belgium, Italy, Spain, United Kingdom, Germany, Hungary, Georgia, Slovakia, Russian Federation, Ukraine, Denmark, Czechia
-
Alder Biopharmaceuticals, Inc.CompletedMigraine DisordersUnited States, Georgia, Australia, New Zealand
-
NGM Biopharmaceuticals, IncCompletedPrimary Sclerosing CholangitisUnited States, France, Netherlands, United Kingdom
-
NGM Biopharmaceuticals, IncCompletedFunctional ConstipationUnited States
-
RegeneRx Biopharmaceuticals, Inc.Terminated
-
Alder Biopharmaceuticals, Inc.Completed
-
Asklepios Biopharmaceutical, Inc.Active, not recruiting
-
Paradigm Biopharmaceuticals USA (INC)Active, not recruitingOsteoarthritis, KneeAustralia, United States
-
Paradigm Biopharmaceuticals USA (INC)Active, not recruitingOsteoarthritis, KneeUnited States, Australia
-
Asklepios Biopharmaceutical, Inc.RecruitingCardiovascular Diseases | Heart Failure | Heart Failure, Diastolic | Congestive Heart Failure | Heart Failure, Systolic | Heart Disease, Ischemic | Heart Failure，Congestive | Heart Arrhythmia | Heart; ComplicationsUnited States
-
Asklepios Biopharmaceutical, Inc.RecruitingCongestive Heart FailureUnited States
-
Asklepios Biopharmaceutical, Inc.RecruitingMuscular Dystrophy | Limb Girdle Muscular Dystrophy | LGMD2I | LGMD | Limb-Girdle Muscular Dystrophy Type 2 | LGMD2 | FKRP | FKRP Mutation | Fukutin Related ProteinUnited States
-
Asklepios Biopharmaceutical, Inc.Active, not recruitingParkinson's Disease | Multiple System Atrophy | Multiple System Atrophy, Parkinson VariantUnited States, Poland
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.RecruitingAdvanced Solid Tumor | Advanced Gastric Carcinoma | Advanced Cholangiocarcinoma | Advanced Lung CancerChina
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.RecruitingOncology | CTLA4 HaploinsufficiencyChina
-
Day One Biopharmaceuticals, Inc.Available
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.TerminatedHematologic MalignancyChina
-
Sichuan Clover Biopharmaceuticals, Inc.TerminatedPeritoneal CarcinomatosisChina
-
Ethicon, Inc.OMRIX BiopharmaceuticalsCompletedBlood Loss, SurgicalUnited States
-
Ethicon, Inc.OMRIX BiopharmaceuticalsCompletedPeripheral Vascular DiseaseUnited States, United Kingdom
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty LtdCompletedNonalcoholic Steatohepatitis (NASH)United States, Australia, Puerto Rico
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty LtdCompletedPrimary Biliary CirrhosisUnited States, Australia, New Zealand
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.RecruitingStudy of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's LymphomaCD20-positive B-cell Non-Hodgkin's LymphomaChina